Table 6.
Alterations in the female reproductive system caused by TiO2 NPs.
Administration/Dose/Species/Size of NPs | Changes | References |
---|---|---|
Intragastric administration 10 mg/kg/day; 90 days ICR mice not specified |
- Accumulation in the ovaries - Hormonal imbalances - Reduced fertility - Disrupted distribution of mineral elements - Oxidative stress |
Gao et al., 2012 [75] |
Per os 100 mg/kg/day; 5 weeks NMRI mice not specified |
- Increased MDA and estrogen levels - Reduction in oocyte count and fertilization rate - Cysts in the ovaries |
Karimipour et al., 2018 [76] |
Intragastric administration 2.5–10 mg/kg/day; 90 days ICR mice not specified |
- Follicular atresia, inflammation, and necrosis - Increased expression of epidermal growth factor, tissue plasminogen activator, interleukin-1β, interleukin-6, tumor necrosis factor-α |
Zhao et al., 2013 [77] |